WG
HCAT icon

Winton Group’s Health Catalyst HCAT Stock Holding History

Winton Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-170,138
Closed -$641K – 856
2025
Q2 		$641K Buy
170,138
+82,336
+94% +$324K 0.03% 540
2025
Q1 		$398K Buy
+87,802
New +$465K 0.02% 538
2021
Q4 		– Sell
-23,674
Closed -$1.18M – 1176
2021
Q3 		$1.18M Buy
23,674
+102
+0.4% +$5.56K 0.07% 416
2021
Q2 		$1.31M Buy
23,572
+643
+3% +$34.3K 0.07% 380
2021
Q1 		$1.07M Buy
22,929
+5,439
+31% +$263K 0.06% 419
2020
Q4 		$761K Sell
17,490
-11,521
-40% -$425K 0.05% 559
2020
Q3 		$1.06M Buy
29,011
+21,697
+297% +$737K 0.03% 799
2020
Q2 		$213K Buy
+7,314
New +$202K 0.01% 1348

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Winton Group's HCAT Position: Q3 2025 in Review

Winton Group sold out of Health Catalyst (HCAT) in Q3 2025, closing a stake of 170,138 shares — an estimated $641K sold.

Winton Group first reported a position in HCAT in Q2 2020 and held it in 8 quarters. The position peaked at $1.31M in Q2 2021. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

  • Winton Group reported no remaining Health Catalyst position as of Q3 2025 after selling out during the quarter.
  • Winton Group sold 170,138 Health Catalyst shares in Q3 2025, an estimated $641K.
  • Winton Group first reported a position in Health Catalyst in Q2 2020 and held it in 8 quarters.
  • Winton Group's Health Catalyst position peaked at $1.31M in Q2 2021.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on Winton Group's 13F filing for Q3 2025, filed 13 Nov 2025.